Texas DIR/ESBD #HHS0017209

Texas DSHS Solicits Bids for Four Illumina MiSeq i100 Plus Sequencing Instruments

The Texas Department of State Health Services (DSHS), part of the Texas Health and Human Services Commission (HHSC), is seeking bids for advanced genetic sequencing equipment to support public health surveillance and research. - Government Buyer: - Texas Department of State Health Services (DSHS), under HHSC Procurement and Contracting Services (PCS) - Contracting office located at 1100 W 49th St, Austin, TX - OEMs and Vendors: - Illumina (Original Equipment Manufacturer of MiSeq i100 Plus) - Bidders may propose alternative brands if all minimum specifications are met and supporting literature is provided - Products Requested: - Four (4) MiSeq i100 Plus sequencing instruments (Illumina, part number 20115695 / MiSeq i100 Plus) - Benchtop next generation sequencers with integrated sequencing, primary and secondary analysis - Features include embedded touchscreen monitors, on-instrument computers, control software, hardware-accelerated Dragen Bio-IT pipelines, and 12-month warranty (parts and labor) - Customer-installable; vendor must provide no-cost reagent replacement for instrument run failures - Customer service available via email or phone during business hours - 20% trade-in discount available for specified MiSeq systems (Serial Numbers: M03431, M04922, M04955, M06018) - Unique or Notable Requirements: - Bidders proposing alternative brands must submit detailed supporting literature for evaluation - All products must meet or exceed stated minimum specifications - Delivery required within 14 days after receipt of order to DSHS Laboratory Building L-114 in Austin, TX - No services are requested; this is strictly for equipment purchase - Both HHSC and DSHS may utilize any resulting contract - Compliance with Texas Public Information Act and contracting information requirements is mandatory

Description

The Texas Department of State Health Services (DSHS) is soliciting bids for 4 MiSeq i100 Plus sequencing instruments from Illumina. These next generation sequencing instruments are used to sequence genetic material from clinical and environmental samples for surveillance, variant detection, outbreak detection, and identifying mutations of interest. Bidders offering alternatives must submit adequate literature for evaluation, and all products must meet the stated minimum specifications. The response deadline is May 20, 2026, at 10:30 AM Central Time.

View original listing